Open AccessWeek 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
Author(s) -
S. Esser,
C. Orkin,
L. Vandekerckhove,
D. Podzamczer,
J. Jezorwski,
M. Opsomer,
E. Van Landuyt,
V. Hufkens,
AMBER study group,
J.J. Eron,
J. Rockstroh,
E. Lathouwers
Publication year - 2020
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/vxxw-nd48
Subject(s) - cobicistat , tenofovir alafenamide , darunavir , emtricitabine , human immunodeficiency virus (hiv) , medicine , virology , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom